After recently taking steps to undo messaging about a rival product in the European Union, CSL Vifor is carrying its amends ...
With Eli Lilly's diabetes and obesity products Mounjaro and Zepbound booming in popularity, the drugmaker finds itself in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback